Medicare rule against broader reimbursement for carotid stenting spurs debate

November 20, 2008 Medicare rule against broader reimbursement for carotid stenting spurs debate By H.A. Abella A decision by the Centers for Medicare and Medicaid Services not to expand coverage for carotid artery stenting has stirred mixed responses among physicians who are either outraged with the denial or satisfied that the decision was scientifically sound. Following the Oct. 14 decision, Medicare reimbursement remains restricted to percutaneous transluminal angioplasty and carotid stenting for patients who are at high risk for carotid endarterectomy and have symptomatic stenosis higher than 70% or are enrolled in an approved clinical trial.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC